Preclinical results showed a restoration of p53 transcriptional activity and increased expression of p21, MDM2, Bax, and PUMA, and oral administration of PC14586 at 100mg/kg in nude mice bearing Y220C gastric cancer xenografts resulted in 80% tumor regression after 3-weeks 115. This evidence concerns the gene TP53 and neoplasm.